These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16563636)

  • 21. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
    Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
    Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
    Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
    J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer.
    Schinagl DA; Vogel WV; Hoffmann AL; van Dalen JA; Oyen WJ; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1282-9. PubMed ID: 17967318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of 18F PET signals for automatic target volume definition in radiotherapy treatment planning.
    Davis JB; Reiner B; Huser M; Burger C; Székely G; Ciernik IF
    Radiother Oncol; 2006 Jul; 80(1):43-50. PubMed ID: 16876272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation.
    Ford EC; Lavely WC; Frassica DA; Myers LT; Asrari F; Wahl RL; Zellars RC
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):595-602. PubMed ID: 18394814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography for target volume definition in the treatment of non-small cell lung cancer.
    Lavrenkov K; Partridge M; Cook G; Brada M
    Radiother Oncol; 2005 Oct; 77(1):1-4. PubMed ID: 16225943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
    Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT.
    Wartski M; Le Stanc E; Gontier E; Vilain D; Banal A; Tainturier C; Pecking AP; Alberini JL
    Nucl Med Commun; 2007 May; 28(5):365-71. PubMed ID: 17414886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET-based treatment planning in radiotherapy: a new standard?
    Grégoire V; Haustermans K; Geets X; Roels S; Lonneux M
    J Nucl Med; 2007 Jan; 48 Suppl 1():68S-77S. PubMed ID: 17204722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evidence on PET-CT for radiation therapy planning in gastro-intestinal tumors.
    Lambrecht M; Haustermans K
    Radiother Oncol; 2010 Sep; 96(3):339-46. PubMed ID: 20727606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
    Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.
    van Loon J; Offermann C; Bosmans G; Wanders R; Dekker A; Borger J; Oellers M; Dingemans AM; van Baardwijk A; Teule J; Snoep G; Hochstenbag M; Houben R; Lambin P; De Ruysscher D
    Radiother Oncol; 2008 Apr; 87(1):49-54. PubMed ID: 18342967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From anatomical to biological target volumes: the role of PET in radiation treatment planning.
    Schinagl DA; Kaanders JH; Oyen WJ
    Cancer Imaging; 2006 Oct; 6(Spec No A):S107-16. PubMed ID: 17114062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
    Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
    Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET/CT-guided radiation therapy planning: from present to the future.
    Gupta T; Beriwal S
    Indian J Cancer; 2010; 47(2):126-33. PubMed ID: 20448373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.